Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
CC BY
Saved in:
Main Authors: | Qian, Zhou, Zhong, Hu, Xin, Li |
---|---|
Format: | Book |
Language: | English |
Published: |
Springer
2023
|
Subjects: | |
Online Access: | https://link.springer.com/article/10.1186/s12890-023-02367-x https://dlib.phenikaa-uni.edu.vn/handle/PNK/6955 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The balance between lung regulatory T cells and Th17 cells is a risk indicator for the acute exacerbation of interstitial lung disease after surgery: a case-control study
by: Mariko, Fukui, et al.
Published: (2023) -
Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry
by: Juergen, Behr, et al.
Published: (2023) -
Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function
by: Fangping, Ding, et al.
Published: (2023) -
A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
by: Han-ping, Duan, et al.
Published: (2023) -
Lung cancer in the emergency department
by: Jeremy R., Walder, et al.
Published: (2023)